XUANZHUBIO-B(02575): Convert 357 million unlisted shares to 357 million H shares.
Xuanzhu Biology-B (02575) announced that on May 12, 2026, 357 million non-listed shares will be converted into 357 million H shares. These H shares will be listed on the Hong Kong Stock Exchange starting from May 13, 2026.
Xuanzhu Bio-B (02575) announces that on May 12, 2026, 357 million privately placed shares will be converted into 357 million H shares. These H shares will begin trading on the Stock Exchange of Hong Kong Limited on May 13, 2026.
Related Articles
ZYLOXTB(02190) spent approximately HKD 1.1362 million to repurchase 51,000 shares on May 12th.
PW MEDTECH (01358) spent 992,000 Hong Kong dollars to repurchase 841,000 shares on May 12th.
CIG Shanghai (06166) will distribute a final dividend of $0.28 per share on June 25th.
ZYLOXTB(02190) spent approximately HKD 1.1362 million to repurchase 51,000 shares on May 12th.
PW MEDTECH (01358) spent 992,000 Hong Kong dollars to repurchase 841,000 shares on May 12th.
CIG Shanghai (06166) will distribute a final dividend of $0.28 per share on June 25th.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
